The Exopulse Mollii Suit from Ottobock is the first full-body neuromodulation suit. It relaxes spastic muscles and activates weaker muscles to reduce chronic pain. It is worn for only one hour a day while still providing the benefits for 24 hours.
Everything you need to know about the features and benefits of the The Exopulse Mollii Suit from Ottobock for spasms and MS need to know.
Stimulation of the antagonistic muscle results in relaxation of the spastic muscle, leading to positive effects in clinical studies regarding range of motion, balance, hand-arm functions and gait. The Exopulse Suit is a non-invasive, novel system based on the physiological reflex mechanism of reciprocal inhibition. This neuromodulating stimulation is a non-invasive and non-drug intervention with fewer side effects compared to conventional invasive and drug treatments for spasticity. This results in positive effects observed in clinical studies in range of motion, balance, hand-arm functions and gait.
The Ottobock Exopulse Mollii Suit consists of a jacket, pants and control unit. It is available in 37 sizes ranging from sizes for 2- to 3-year-olds, including additional sizes for children, and up to 5XL for women and men. There are 58 electrodes integrated into the Exopulse Suit for stimulation of 40 major muscle groups. This allows for more than 30 different settings per muscle group using 20 Hz subthreshold transcutaneous electrical nerve stimulation (TENS).
Neuromodulation alters nerve activity to elicit a natural biological response. Through the use of neuromodulation, target areas can be provided with electrical stimuli to alter nerve activity. Neuromodulation is a technique that acts on nerves to cause a response. Due to neurological disease, an antagonistic muscle does not receive a signal naturally. By sending an electrical signal to the antagonistic muscle, relaxation of the muscle is induced.
Spasticity can be caused by damage to the central nervous system (CNS) and means a pathological increase in muscle tone. Spasticity can severely limit the quality of life.
Spasticity, spasm or spasticity is caused by damage to the central nervous system (CNS) and means an abnormal increase in muscle tone.
Triggers include neurological indications, examples:
The increased muscle tension leads to permanent hardening and stiffening, known as spastic paralysis.
The Exopulse Suit is a soft orthosis for electrostimulation consisting of pants, a top and a removable control unit. 58 electrodes, aligned to affect up to 40 relevant muscles, are located in the components. The Exopulse Suit can be worn by both children and adults.
A low frequency electrical stimulus stimulates the antagonist/opponent of the spastic muscle. The Exopulse Suit is a simple and safe tool to relax spastic muscles to improve mobility and function. It has been proven in many clinical studies that the Exopulse Suit has a simple and safe mode of action. For example, if the biceps are spastic, the triceps are stimulated, which in turn relaxes the biceps. The relaxation of the spastic muscle thus allows active movement, gradual improvement of function, and pain reduction.
For best results, the Exopulse Suit should be worn every other day, for approximately one hour.
We recommend using this in conjunction with physiotherapy, training or exercise in general.
Basically, the Exopulse Mollii Suit is suitable for sequelae of neurological diseases, primarily the Exopulse Mollii Suit Parkinson.
Primary patient group:
The Exopulse Suit is not to be used::
Use Exopulse Suit in connection with any of the following circumstances only after prior consultation with your doctor!
Paexo is the industrial brand of Ottobock, the world's largest provider of orthotic, prosthetic and exoskeletal solutions and stands for "Passive Exoskeleton". Mollii Suit was founded by Fredrik Lundqvist. Later, Nicolas Loren Abboud and Malte Binting joined the team as co-founders. Later, the company was acquired by Ottobock in 2021 to strengthen the Neuro Orthetics division.
Image sources: All images and graphics are copyrighted and property of ©.
Otto Bock HealthCare Deutschland GmbH.